Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2021 | WST11 vascular-targeted photodynamic therapy in UTUC

Lucas Nogueira • 15 Feb 2021
GU Cancers 2021
Genitourinary Cancer Urothelial Carcinoma

Lucas Nogueira, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, describes the Phase I study of WST11 vascular-targeted photodynamic therapy (VTP), which involves the intravascular photosensitizing agent padeliporfin, in patients with upper tract urothelial carcinoma (UTUC). In this study, WST11 VTP demonstrated a promising therapeutic effect in low- and high-grade UTUC with limited treatment-related toxicity and suggests further investigation of this therapy is warranted. This interview took place during the 2021 Genitourinary Cancers Symposium.

More from Lucas Nogueira

Vascular-targeted photodynamic therapy
4:12
Vascular-targeted photodynamic therapy
Lucas Nogueira • 15 Feb 2021

Related Videos

Decipher score predicts metastasis risk and abiraterone benefit in prostate cancer
1:55
Decipher score predicts metastasis risk and abiraterone benefit in prostate cancer
Sarah Howlett • 26 Oct 2026
KEYNOTE-866: perioperative pembrolizumab with chemotherapy in MIBC
2:20
KEYNOTE-866: perioperative pembrolizumab with chemotherapy in MIBC
Jens Bedke • 26 Oct 2026
The evolving role of EV plus immunotherapy in muscle-invasive bladder cancer
2:24
The evolving role of EV plus immunotherapy in muscle-invasive bladder cancer
Jens Bedke • 26 Oct 2026
EV-303: long-term subgroup outcomes with EV and pembrolizumab in la/mUC
2:58
EV-303: long-term subgroup outcomes with EV and pembrolizumab in la/mUC
Jens Bedke • 26 Oct 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals